Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
245.26
-1.02 (-0.41%)
Feb 25, 2026, 11:52 AM EST - Market open

Johnson & Johnson Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
94,19388,82185,15979,99078,740
Revenue Growth (YoY)
6.05%4.30%6.46%1.59%-4.66%
Cost of Revenue
30,25627,47126,55324,59623,402
Gross Profit
63,93761,35058,60655,39455,338
Selling, General & Admin
23,67622,86921,51220,24620,118
Research & Development
14,66517,23215,08514,13514,277
Other Operating Expenses
3094458021,0581,109
Operating Expenses
38,65040,54637,39935,43935,504
Operating Income
25,28720,80421,20719,95519,834
Interest Expense (Income)
971755772276183
Other Expense (Income)
-8,2653,362-16,454-1,251-2,604
Pretax Income
32,58116,68736,88920,93022,255
Income Tax
5,7772,6211,7362,9891,377
Net Income
26,80414,06635,15317,94120,878
Net Income Growth
90.56%-59.99%95.94%-14.07%41.89%
Shares Outstanding (Basic)
2,4072,4072,5342,6252,632
Shares Outstanding (Diluted)
2,4292,4292,5602,6642,674
Shares Change
--5.12%-3.89%-0.38%0.12%
EPS (Basic)
11.135.8413.886.837.93
EPS (Diluted)
11.035.7913.726.737.81
EPS Growth
90.50%-57.80%103.86%-13.83%41.74%
Free Cash Flow
19,69819,84218,24817,18519,758
Free Cash Flow Per Share
8.188.247.206.557.51
Dividend Per Share
5.1404.9104.7004.4504.190
Dividend Growth
4.68%4.47%5.62%6.21%5.28%
Gross Margin
67.88%69.07%68.82%69.25%70.28%
Operating Margin
26.85%23.42%24.90%24.95%25.19%
Profit Margin
28.46%15.84%41.28%22.43%26.52%
Free Cash Flow Margin
20.91%22.34%21.43%21.48%25.09%
Effective Tax Rate
17.73%15.71%4.71%14.28%6.19%
EBITDA
41,05524,78145,14728,17629,828
EBITDA Margin
43.59%27.90%53.02%35.22%37.88%
Depreciation & Amortization
7,5037,3397,4866,9707,390
EBIT
33,55217,44237,66121,20622,438
EBIT Margin
35.62%19.64%44.22%26.51%28.50%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).